|
PIAS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.585360E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.811800E-01 |
| Normal-vs-Stage2 |
6.066600E-01 |
| Normal-vs-Stage3 |
2.680900E-03 |
| Normal-vs-Stage4 |
2.120200E-03 |
| Stage1-vs-Stage2 |
3.457800E-01 |
| Stage1-vs-Stage3 |
1.379110E-04 |
| Stage1-vs-Stage4 |
1.420880E-04 |
| Stage2-vs-Stage3 |
8.132300E-02 |
| Stage2-vs-Stage4 |
5.237500E-02 |
| Stage3-vs-Stage4 |
6.125600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.599200E-01 |
| Normal-vs-AfricanAmerican |
1.537140E-03 |
| Normal-vs-Asian |
1.109970E-01 |
| Caucasian-vs-AfricanAmerican |
1.134080E-02 |
| Caucasian-vs-Asian |
1.917780E-02 |
| AfricanAmerican-vs-Asian |
8.580300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.267390E-01 |
| Normal-vs-Female |
3.855000E-01 |
| Male-vs-Female |
5.289600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.442200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.036400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.148210E-01 |
| Normal-vs-Age(81-100Yrs) |
1.612390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.614000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.805400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.176200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.334800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.340000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.863000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.243210E-01 |
| Normal-vs-Grade 2 |
8.024600E-01 |
| Normal-vs-Grade 3 |
5.278000E-02 |
| Normal-vs-Grade 4 |
8.047100E-04 |
| Grade 1-vs-Grade 2 |
2.819200E-01 |
| Grade 1-vs-Grade 3 |
5.069900E-02 |
| Grade 1-vs-Grade 4 |
4.340600E-03 |
| Grade 2-vs-Grade 3 |
1.622360E-02 |
| Grade 2-vs-Grade 4 |
3.174400E-04 |
| Grade 3-vs-Grade 4 |
5.833800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.690300E-02 |
| Normal-vs-ccB subtype |
9.314200E-02 |
| ccA subtype-vs-ccB subtype |
2.840300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.578200E-01 |
| Normal-vs-N1 |
1.862450E-01 |
| N0-vs-N1 |
2.634400E-01 |
|
|
